Feasibility and guidelines for the use of an injectable fiducial marker (BioXmark ® ) to improve target delineation in preclinical radiotherapy studies using mouse models.

can help to standardise targeting methods, improve alignment in preclinical image-guided RT and significantly improve the welfare of experimental animals with the reduction of normal tissue exposure to RT.